BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10700002)

  • 1. Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization Of Ki67 (MIB1) assessment in routinely processed urinary bladder carcinoma tissue.
    Wester K; Andersson AC; Ranefall P; Bengtsson E; Malmström PU; Busch C
    J Pathol; 2000 Mar; 190(4):503-11. PubMed ID: 10700002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an optimal protocol for antigen retrieval: a 'test battery' approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections.
    Shi SR; Cote RJ; Yang C; Chen C; Xu HJ; Benedict WF; Taylor CR
    J Pathol; 1996 Jul; 179(3):347-52. PubMed ID: 8774494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen.
    Wester K; Wahlund E; Sundström C; Ranefall P; Bengtsson E; Russell PJ; Ow KT; Malmström PU; Busch C
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):61-70. PubMed ID: 10937051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.
    Cowen D; Troncoso P; Khoo VS; Zagars GK; von Eschenbach AC; Meistrich ML; Pollack A
    Clin Cancer Res; 2002 May; 8(5):1148-54. PubMed ID: 12006531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-induced modification of protein conformation demonstrated by immunohistochemistry: What is the signal?
    Shi SR; Cote RJ; Hawes D; Thu S; Shi Y; Young LL; Taylor CR
    J Histochem Cytochem; 1999 Apr; 47(4):463-70. PubMed ID: 10082747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
    Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
    Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis.
    Shi SR; Liu C; Taylor CR
    J Histochem Cytochem; 2007 Feb; 55(2):105-9. PubMed ID: 16982846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
    Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
    J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 immunostaining on cytological samples: a protocol without antigen retrieval.
    Kirbis IS; Flezar MS; Krasovec MU
    Cytopathology; 2004 Jun; 15(3):154-9. PubMed ID: 15165272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical markers in urinary bladder carcinomas from paraffin-embedded archival tissue after storage for 5-70 years.
    Litlekalsoy J; Vatne V; Hostmark JG; Laerum OD
    BJU Int; 2007 May; 99(5):1013-9. PubMed ID: 17437436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody.
    Mazerolles C; Rishmann P; Chopin D; Popov Z; Malavaud B; Selves J; Neulat-Duga I; Bellot J; Delsol G
    Histopathology; 1994 Dec; 25(6):563-8. PubMed ID: 7698733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic quantification of immunohistochemically stained cell nuclei based on standard reference cells.
    Ranefall P; Wester K; Andersson AC; Busch C; Bengtsson E
    Anal Cell Pathol; 1998; 17(2):111-23. PubMed ID: 10052635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
    Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
    Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of immunohistochemistry for biomarker assessment--can it compete with other technologies?
    Dunstan RW; Wharton KA; Quigley C; Lowe A
    Toxicol Pathol; 2011 Oct; 39(6):988-1002. PubMed ID: 21971934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.